Establishment of an in vitro assay to measure the invasion of ovarian carcinoma cells through mesothelial cell monolayers
- PMID: 12856722
- DOI: 10.1023/a:1024009131191
Establishment of an in vitro assay to measure the invasion of ovarian carcinoma cells through mesothelial cell monolayers
Abstract
Ovarian carcinoma is the leading cause of gynecological cancer deaths in the United States. Secondary tumor growths form by tumor cell invasion through the mesothelial lining of the peritoneal cavity and peritoneal organs. To study this interaction, we developed a dye-based in vitro model system in which mesothelial cells were grown as confluent monolayers, permeabilized, and then co-cultured with ovarian carcinoma cells for up to seven days. The mesothelial cells were then stained with trypan blue dye, which enabled the visualization of ovarian carcinoma cell invasion through the monolayers of mesothelial cells. Ovarian carcinoma cell invasion was inhibited for up to 7 days by the addition of GRGDSP peptides, a blocking monoclonal antibody against the beta1 integrin subunit, or blocking monoclonal antibodies against matrix metalloproteinases 2 and 9. Cell invasion was also inhibited by hyaluronan and GM6001, a chemical inhibitor of matrix metalloproteinases. Differential gene expression of matrix metalloproteinases, tissue inhibitors of matrix metalloproteinases, and disintegrins were observed in primary ovarian carcinoma tumors and secondary metastases, compared to normal ovaries. Taken together, these results suggest that complex interactions between integrins, disintegrins, matrix metalloproteinases, and tissue inhibitors of matrix metalloproteinases may mediate ovarian carcinoma cell invasion, and that the dye-based assay described herein is a suitable model system for its study.
Similar articles
-
Ovarian carcinoma spheroids disaggregate on type I collagen and invade live human mesothelial cell monolayers.Clin Exp Metastasis. 2004;21(8):685-97. doi: 10.1007/s10585-004-5768-5. Clin Exp Metastasis. 2004. PMID: 16035613
-
CD44 and beta1 integrin mediate ovarian carcinoma cell adhesion to peritoneal mesothelial cells.Am J Pathol. 1999 May;154(5):1525-37. doi: 10.1016/s0002-9440(10)65406-5. Am J Pathol. 1999. PMID: 10329605 Free PMC article.
-
CD44 and beta1 integrins mediate ovarian carcinoma cell migration toward extracellular matrix proteins.Clin Exp Metastasis. 2000;18(1):67-75. doi: 10.1023/a:1026519016213. Clin Exp Metastasis. 2000. PMID: 11206841
-
Relationship between matrix metalloproteinases and the occurrence and development of ovarian cancer.Braz J Med Biol Res. 2017 May 18;50(6):e6104. doi: 10.1590/1414-431X20176104. Braz J Med Biol Res. 2017. PMID: 28538838 Free PMC article. Review.
-
[The role of selected matrix metalloproteinases and their inhibitors in colorectal cancer development].Postepy Hig Med Dosw (Online). 2010 Jan 26;64:22-30. Postepy Hig Med Dosw (Online). 2010. PMID: 20173217 Review. Polish.
Cited by
-
Establishment of the SIS scaffold-based 3D model of human peritoneum for studying the dissemination of ovarian cancer.J Tissue Eng. 2022 Mar 23;13:20417314221088514. doi: 10.1177/20417314221088514. eCollection 2022 Jan-Dec. J Tissue Eng. 2022. PMID: 35340423 Free PMC article.
-
Role of versican, hyaluronan and CD44 in ovarian cancer metastasis.Int J Mol Sci. 2011 Jan 31;12(2):1009-29. doi: 10.3390/ijms12021009. Int J Mol Sci. 2011. PMID: 21541039 Free PMC article. Review.
-
Claudin 4 Is differentially expressed between ovarian cancer subtypes and plays a role in spheroid formation.Int J Mol Sci. 2011 Feb 22;12(2):1334-58. doi: 10.3390/ijms12021334. Int J Mol Sci. 2011. PMID: 21541062 Free PMC article.
-
Modeling the Early Steps of Ovarian Cancer Dissemination in an Organotypic Culture of the Human Peritoneal Cavity.J Vis Exp. 2015 Dec 31;(106):e53541. doi: 10.3791/53541. J Vis Exp. 2015. PMID: 26780294 Free PMC article.
-
Role of tumor microenvironment in the pathobiology of ovarian cancer: Insights and therapeutic opportunities.Cancer Med. 2018 Oct;7(10):5047-5056. doi: 10.1002/cam4.1741. Epub 2018 Aug 21. Cancer Med. 2018. PMID: 30133163 Free PMC article. Review.
References
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical